Literature DB >> 26113768

Adenosine Receptors: The Contributions by John W. Daly.

Bertil B Fredholm1, Kenneth A Jacobson2.   

Abstract

John Daly played an important role in defining adenosine receptors as an important target for drug discovery. His systematic work characterized the effects of adenosine analogues on cyclic AMP in the brain that were antagonized by methylxanthines. He also played a decisive role in establishing these receptors as bona fide biochemical entities and contributed to the discovery of receptor heterogeneity. This brief review will cover some of his important early discoveries in the pharmacology and medicinal chemistry of adenosine receptors.

Entities:  

Year:  2009        PMID: 26113768      PMCID: PMC4477965          DOI: 10.3987/COM-08-S(D)Memoire-2

Source DB:  PubMed          Journal:  Heterocycles        ISSN: 0385-5414            Impact factor:   0.831


  44 in total

1.  EFFECTS OF CAFFEINE ON MAMMALIAN ATRIAL MUSCLE, AND ITS INTERACTION WITH ADENOSINE AND CALCIUM.

Authors:  T DEGUBAREFF; W SLEATOR
Journal:  J Pharmacol Exp Ther       Date:  1965-05       Impact factor: 4.030

2.  Alkylxanthines: inhibition of adenosine-elicited accumulation of cyclic AMP in brain slices and of brain phosphodiesterase activity.

Authors:  F W Smellie; C W Davis; J W Daly; J N Wells
Journal:  Life Sci       Date:  1979-06-25       Impact factor: 5.037

3.  Factors influencing the accumulation of cyclic AMP in brain tissue.

Authors:  T W Rall; A Sattin
Journal:  Adv Biochem Psychopharmacol       Date:  1970

4.  A radioisotopic method for measuring the formation of adenosine 3',5'-cyclic monophosphate in incubated slices of brain.

Authors:  H Shimizu; J W Daly; C R Creveling
Journal:  J Neurochem       Date:  1969-12       Impact factor: 5.372

5.  Studies on adenosine 3',5'-phosphate in rabbit cerebral cortex.

Authors:  S Kakiuchi; T W Rall
Journal:  Mol Pharmacol       Date:  1968-07       Impact factor: 4.436

Review 6.  Adenosine receptors in the central nervous system: relationship to the central actions of methylxanthines.

Authors:  J W Daly; R F Bruns; S H Snyder
Journal:  Life Sci       Date:  1981-05-11       Impact factor: 5.037

7.  Cyclic adenosine 3',5'-monophosphate in guinea pig cerebral cortical slices. I. Formation of cyclic adenosine 3',5'-monophosphate from endogenous adenosine triphosphate and from radioactive adenosine triphosphate formed during a prior incubation with radioactive adenine.

Authors:  J Schultz; J W Daly
Journal:  J Biol Chem       Date:  1973-02-10       Impact factor: 5.157

8.  Cyclic adenosine 3',5'-monophosphate in guinea pig cerebral cortical slices. II. The role of phosphodiesterase activity in the regulation of levels of cyclic adenosine 3',5'-monophosphate.

Authors:  J Schultz; J W Daly
Journal:  J Biol Chem       Date:  1973-02-10       Impact factor: 5.157

9.  N6-substituted 9-methyladenines: a new class of adenosine receptor antagonists.

Authors:  D Ukena; W L Padgett; O Hong; J W Daly; D T Daly; R A Olsson
Journal:  FEBS Lett       Date:  1987-05-11       Impact factor: 4.124

10.  Adenosine receptors and behavioral actions of methylxanthines.

Authors:  S H Snyder; J J Katims; Z Annau; R F Bruns; J W Daly
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

View more
  4 in total

Review 1.  Xanthines as adenosine receptor antagonists.

Authors:  Christa E Müller; Kenneth A Jacobson
Journal:  Handb Exp Pharmacol       Date:  2011

Review 2.  Introduction to adenosine receptors as therapeutic targets.

Authors:  Kenneth A Jacobson
Journal:  Handb Exp Pharmacol       Date:  2009

3.  Caffeine intake and risk of neural tube defects.

Authors:  Pietro Cavalli; Ugo Cavallari; Vittorio Unfer; Gabriele Tonni
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-11-15

Review 4.  John Daly Lecture: Structure-guided Drug Design for Adenosine and P2Y Receptors.

Authors:  Kenneth A Jacobson; Zhan-Guo Gao; Silvia Paoletta; Evgeny Kiselev; Saibal Chakraborty; P Suresh Jayasekara; Ramachandran Balasubramanian; Dilip K Tosh
Journal:  Comput Struct Biotechnol J       Date:  2014-10-16       Impact factor: 7.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.